{"denoms":[{"counts":[{"groupId":"BG000","value":"93"},{"groupId":"BG001","value":"92"},{"groupId":"BG002","value":"92"},{"groupId":"BG003","value":"277"}],"units":"Participants"}],"groups":[{"description":"Patients receive azacitidine SC or IV on days 1-7 or days 1-5 and 8-9, and lenalidomide PO QD on days 1-21. Courses repeat every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity.\n\nAzacitidine: Given SC or IV\n\nLenalidomide: Given PO","id":"BG000","title":"Arm 1: Azacitidine/Lenalidomide"},{"description":"Patients receive azacitidine as in Arm 1. Courses repeat every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity.\n\nAzacitidine: Given SC or IV","id":"BG001","title":"Arm 2: Azacitidine"},{"description":"Patients receive azacitidine as in Arm 1 and vorinostat PO BID on days 3-9. Courses repeat every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity.\n\nAzacitidine: Given SC or IV\n\nVorinostat: Given PO","id":"BG002","title":"Arm 3: Azacitidine/Vorinostat"},{"description":"Total of all reporting groups","id":"BG003","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"51.29","upperLimit":"86.68","value":"70.81"},{"groupId":"BG001","lowerLimit":"42.69","upperLimit":"88.96","value":"69.67"},{"groupId":"BG002","lowerLimit":"28.69","upperLimit":"93.01","value":"70.36"},{"groupId":"BG003","lowerLimit":"28.69","upperLimit":"93.01","value":"70.18"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"32"},{"groupId":"BG001","value":"31"},{"groupId":"BG002","value":"22"},{"groupId":"BG003","value":"85"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"61"},{"groupId":"BG001","value":"61"},{"groupId":"BG002","value":"70"},{"groupId":"BG003","value":"192"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"2"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"2"},{"groupId":"BG003","value":"7"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"1"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"4"},{"groupId":"BG003","value":"9"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"86"},{"groupId":"BG001","value":"80"},{"groupId":"BG002","value":"83"},{"groupId":"BG003","value":"249"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"9"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"}],"populationDescription":"Analysis includes eligible patients only."}